Business context and reporting period
Entity and period: The supplied filing is Park City Group, Inc.’s Form 10-K for the fiscal year ended June 30, 2013—not a ReposiTrak, Inc. filing or a report for 2012 Q4. ReposiTrak is described as a separate venture with which Park City Group has service, management, and technology agreements.
Park City Group provides SaaS supply-chain software and related consulting to retailers, suppliers, and manufacturers. Its strategy is shifting toward recurring subscriptions, which represented 71% of revenue in fiscal 2013.
Financial results and position
| Metric | FY2013 | FY2012 |
|---|---|---|
| Revenue | $11.32 million | $10.10 million |
| Subscription revenue | $8.03 million | $6.99 million |
| Operating income (loss) | $398,199 | $(972,712) |
| Net income (loss) | $257,487 | $(858,667) |
| Net loss applicable to common shareholders, after preferred dividends | $(654,093) | $(1.69 million) |
| Operating cash flow | $(149,064) | $866,616 |
- Revenue increased 12%; subscriptions rose 15%. Cost of revenue and product support was 40% of revenue versus 45% in FY2012. Operating margin was approximately 3.5%, compared with a loss from operations in the prior year.
- Cash and cash equivalents were $3.62 million, up from $1.11 million. Working capital improved to positive $1.12 million from negative $2.35 million.
- Total liabilities were $5.69 million. Debt included a $1.20 million line of credit, $862,063 of notes payable, and no remaining capital lease obligations. The line of credit matured December 31, 2013; scheduled note maturities included $551,421 in FY2014.
- Investing cash outflow was $445,744; financing cash inflow was $3.11 million, primarily reflecting the March 2013 equity offerings.
Material changes versus the prior comparable period
- Net income improved from a loss to a profit, but the company still reported a loss attributable to common shareholders because preferred dividends were $911,580.
- Operating cash flow declined by about $1.02 million and turned negative. Management attributed the cash use principally to operating-asset and liability movements, including higher receivables; $1.62 million of receivables was converted into a note receivable.
- Subscription growth was partly offset by approximately $802,000 of revenue lost from non-renewals, including a significant retail customer. Professional-services revenue fell approximately $379,000.
- Cash and working capital rose substantially, chiefly because of approximately $4.34 million raised through a private offering and director investment. The Series A preferred stock was largely converted into common shares; only 2,172 preferred shares were redeemed for cash.
Outlook, commentary, risks, and unusual items
- Management expected subscription revenue to continue increasing year over year and believed existing cash, short-term investments, and operating funds would cover operations and debt service for at least 12 months. These are expectations, not quantified revenue or earnings guidance.
- The company cited a three-year CVS service agreement and pilot programs with two national retailers as growth opportunities; the filing gives no clear revenue forecast for these prospects.
- ReposiTrak generated approximately $1.88 million of FY2013 revenue under the prior agreements, including about $1.6 million represented by a promissory note issued to Park City Group. The filing also reports approximately $1.3 million of ReposiTrak subscription fees. Collection and repayment are important credit risks.
- A June 30, 2013 agreement continued Park City Group’s services and technology support to ReposiTrak for three years and granted Park City Group a nine-year option to acquire approximately 75% of ReposiTrak, subject to specified prices and terms.
- Key risks include subscription renewals and customer concentration, reliance on growth and effective execution, competition and technology change, hosting or security interruptions, and the company’s ability to refinance or repay debt. Management acknowledged that liquidity plans depend on projected cash flow and possible refinancing or restructuring.
- Other notable matters: the company authorized a share repurchase program of up to $2 million but was not obligated to buy shares; it reported no pending or threatened legal proceedings. A new post-year-end services agreement with the CEO’s controlled company set an annual base fee of $500,000, among other compensation terms.
Important facts for investors to verify
- Confirm the intended issuer and period: this is Park City Group’s FY2013 10-K, not a ReposiTrak filing or 2012 Q4 report.
- Assess collectability, timing, and terms of the $1.62 million ReposiTrak note receivable and any additional fees payable by ReposiTrak.
- Review the post-year-end status and terms of the credit line, near-term note maturities, and any refinancing or debt repayment.
- Reconcile reported net income with the common-shareholder loss after preferred dividends, and track whether operating cash flow improves.
- Check subscription renewals, customer additions, and conversion of CVS and retailer pilots into revenue-producing contracts.
- Review dilution from the equity offerings, warrants, preferred-stock conversion, and related-party compensation arrangements.